4x0k

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (07:39, 27 September 2023) (edit) (undo)
 
(5 intermediate revisions not shown.)
Line 1: Line 1:
 +
==Engineered Fab fragment specific for EYMPME (EE) peptide==
==Engineered Fab fragment specific for EYMPME (EE) peptide==
-
<StructureSection load='4x0k' size='340' side='right' caption='[[4x0k]], [[Resolution|resolution]] 2.04&Aring;' scene=''>
+
<StructureSection load='4x0k' size='340' side='right'caption='[[4x0k]], [[Resolution|resolution]] 2.04&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[4x0k]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4X0K OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4X0K FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[4x0k]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4X0K OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4X0K FirstGlance]. <br>
-
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4x0k FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x0k OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4x0k RCSB], [http://www.ebi.ac.uk/pdbsum/4x0k PDBsum]</span></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.04&#8491;</td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4x0k FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x0k OCA], [https://pdbe.org/4x0k PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4x0k RCSB], [https://www.ebi.ac.uk/pdbsum/4x0k PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4x0k ProSAT]</span></td></tr>
</table>
</table>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Crystallization chaperones are attracting increasing interest as a route to crystal growth and structure elucidation of difficult targets such as membrane proteins. While strategies to date have typically employed protein-specific chaperones, a peptide-specific chaperone to crystallize multiple cognate peptide epitope-containing client proteins is envisioned. This would eliminate the target-specific chaperone-production step and streamline the co-crystallization process. Previously, protein engineering and directed evolution were used to generate a single-chain variable (scFv) antibody fragment with affinity for the peptide sequence EYMPME (scFv/EE). This report details the conversion of scFv/EE to an anti-EE Fab format (Fab/EE) followed by its biophysical characterization. The addition of constant chains increased the overall stability and had a negligible impact on the antigen affinity. The 2.0 A resolution crystal structure of Fab/EE reveals contacts with larger surface areas than those of scFv/EE. Surface plasmon resonance, an enzyme-linked immunosorbent assay, and size-exclusion chromatography were used to assess Fab/EE binding to EE-tagged soluble and membrane test proteins: namely, the beta-barrel outer membrane protein intimin and alpha-helical A2a G protein-coupled receptor (A2aR). Molecular-dynamics simulation of the intimin constructs with and without Fab/EE provides insight into the energetic complexities of the co-crystallization approach.
 +
 +
Structural and biophysical characterization of an epitope-specific engineered Fab fragment and complexation with membrane proteins: implications for co-crystallization.,Johnson JL, Entzminger KC, Hyun J, Kalyoncu S, Heaner DP Jr, Morales IA, Sheppard A, Gumbart JC, Maynard JA, Lieberman RL Acta Crystallogr D Biol Crystallogr. 2015 Apr;71(Pt 4):896-906. doi:, 10.1107/S1399004715001856. Epub 2015 Mar 27. PMID:25849400<ref>PMID:25849400</ref>
 +
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 4x0k" style="background-color:#fffaf0;"></div>
 +
== References ==
 +
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Johnson, J L]]
+
[[Category: Homo sapiens]]
-
[[Category: Lieberman, R L]]
+
[[Category: Large Structures]]
-
[[Category: Antibody fragment]]
+
[[Category: Johnson JL]]
-
[[Category: Crystallization chaperone]]
+
[[Category: Lieberman RL]]
-
[[Category: Fab fragment]]
+
-
[[Category: Immune system]]
+

Current revision

Engineered Fab fragment specific for EYMPME (EE) peptide

PDB ID 4x0k

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools